Vivien Yui

Practice Areas

Vivien Yui is the Co-Head of the Employment Practice and is a Partner in the Mergers & Acquisitions, Business Establishment, Corporate Governance & Compliance, Health Sciences & Biotechnology, Professional Services and Philippines Practices. Her main practice areas are private mergers and acquisitions, employment, corporate governance and compliance and general corporate and commercial work.

Vivien practises general corporate law, with an emphasis on representing private equity investments, especially in biotechnology and biomedical companies. As the Joint Head of the Firm's Employment Practice, she regularly advises multinational corporations on their global share incentive plans and establishment of local employment practices, benefits and policies. She also assists clients with immigration law and regulatory issues.

Publications

- The Legal 500: Country Comparative Guides – Singapore – Employee Incentives, 2024

- Thomson Reuters Practical Law Employee Share Plans Global Guide 2024 - Singapore Chapter

- LegisWatch: New Tripartite Guidelines on Flexible Work Arrangement Requests Effective December 2024

- LegisWatch: SGX RegCo Requires Large Issuers to Take Lead to Reduce AGM Crunch, Reserve AGM Slots in Advance

- LegisWatch: Changes to Mandatory Training Requirement for First-time Directors of SGX-listed Issuers

- LegisWatch: Changes to Conduct of Meetings: Companies, Business Trusts and Other Bodies (Miscellaneous Amendments) Act 2023 and Listing Manual Practice Notes on General Meetings

- LegisWatch: Changes to the Global Investor Programme

- LegisWatch: Changes to Listing Rules: Tenure of Independent Directors Capped at Nine Years; Remuneration of Directors and CEOs Must Be Disclosed

- LegisWatch: Budget 2023 – Employment Updates

- LegisWatch: Enhanced Tripartite Guidelines on Exercising Sensitivity for Harmonious Workplace

Work Highlights

Significant transactions that Vivien has been involved in include advising / acting for the following:

- GlaxoSmithKline plc ("GSK"), as Singapore counsel, on corporate/commercial and employment matters in relation to GSK's three-part transaction with Novartis International AG ("Novartis") pursuant to which GSK acquired Novartis's global vaccines business (excluding influenza vaccines) for an initial cash consideration of US$5.25 billion. The deal was one of the winning deals in Asian-Mena Counsel Deals of the Year, 2015.

- ESR Funds Management (S) Limited (the manager of ESR-REIT), in the merger with Viva Industrial Trust by way of a trust scheme of arrangement. The merger values Viva Industrial Trust at S$936.7 million and creates Singapore's fourth largest industrial REIT with approximately S$3 billion in property assets. This deal won Best Singapore Deal at the FinanceAsia Awards 2018 and M&A Deal of the Year (Midsize) at the ALB SE Asia Law Awards, 2019.

- Clearbridge Health Limited ("CBH") in the acquisition of 49% of the issued and paid-up share capital of PT Tirta Medika Jaya ("TMJ") by Clearbridge Medical Asia Pte. Ltd., an indirect wholly-owned subsidiary of CBH, from Ark Investments (SG) Pte. Ltd. In connection with the Acquisition, CBMA also subscribed for an exchangeable bond issued by PT Genesis Kapital Investama, one of the shareholders of TMJ.

- Clearbridge BioMedics Pte. Ltd. in its S$6.6 million pre-IPO financing and the consolidation of its capital structure by converting all preferred shares and convertible securities to ordinary shares of Clearbridge BioMedics in preparation for the potential IPO.

- EFG BANK AG, Singapore Branch in the acquisition of BSI Bank Limited's Singapore private banking business. This follows the announcement on 22 February 2016 by EFG International and BSI Bank that EFG International will acquire BSI Bank to form one of the largest private banks in Switzerland with approximately CHF 170 billion in assets under management, for a purchase price of approximately CHF 1,328 million.

- Skyworks Solutions, Inc., in the labour and work visa matters in relation to its joint venture with Panasonic Corporation to design, develop and deliver high performance filters, including surface acoustic wave ("SAW") devices and temperature compensated SAW devices ("TC-SAW") and the acquisition by the joint venture of Panasonic Corporation's SAW and TC-SAW business in Singapore.